Return to Normal View

Practitioner Profile - Virginia Board of Medicine

Unless otherwised indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Printer Friendly Version Printer Icon
 

Victor Youssef Yazbeck, MD

LICENSE # 0101254726
 
Issue Date: 8/9/2013
Expiration Date: 3/31/2026
Status: Current Active


Disclaimer: General
The following information contained in this database is provided from the records of the Board of Medicine.

The Department and the Board have taken measures to assure that the above information reflects information contained in records that it maintains consistent with its statutory responsibility to doctors of medicine, osteopathy, and podiatry.

The following information is required to be self-reported by licensees under penalty of law. This information is not verified by the Board. The Department and the Board have the authority to investigate reported inaccuracies in the displayed information and if warranted, seek correction and effect licensee compliance with the law and regulations governing the practitioner information system.

Required information provided by doctors:

Optional information doctors may choose to include:


The Board does not comprehensively verify the information required to be self-reported by doctors, and therefore does not accept responsibility for the accuracy of self-reported information. The Board conducts periodic random audits of profiles as an effort to improve the accuracy and timeliness of the information.

Please note that if a practitioner's license is not active, they are under no obligation to update their profile so the information contained in that profile may not be up-to-date.



Disclaimer: Malpractice Information

When considering malpractice paid claims data, please keep in mind:


Some studies have shown little correlation between the existence of a malpractice paid claims history and the practitioner's competence to provide care.

Malpractice paid claims histories tend to vary by specialty. Some specialties are more likely than others to be the subject of litigation.

Some doctors work primarily with high-risk patients. These doctors may have malpractice paid claims histories that are higher than average because they specialize in cases or patients who are at very high risk for problems.

Settlement of a claim may occur for a variety of reasons, which do not necessarily reflect negatively on the professional competence or conduct of the practitioner. A payment in settlement of a medical malpractice action or claim should not be construed as creating a presumption that medical malpractice has occurred.

The incident causing the malpractice paid claim may have happened years before a payment is finally made. Sometimes, it takes a long time for a malpractice lawsuit to move through the legal system.

Presentation of Required Data:

As of July 1, 2007, practitioners are required to report all paid claims over $10,000 in the last 10 years. For doctors practicing less than 10 years, the data covers their total years of practice.

To provide perspective regarding the reported data, the Board displays information about the paid claims experience of the practitioner's specialty along with the practitioner's history of paid claims. In reporting the data in this manner, each practitioner is seen relative to other practitioners in the specialty, rather than to all practitioners in all specialties.

Paid claims are not expressed in dollar amounts. Each paid claim has been analyzed and assigned to one of three statistical categories: below average, average, or above average. This analysis was made relative to the other claims in the specialty in which the claim occurred.

The information provided, in the manner provided, should offer perspective about this aspect of medical practice. You could miss an opportunity for high quality care by excluding a doctor based solely on the presence of a malpractice history. You may wish to discuss information provided in this report, and malpractice generally, with your doctor.



Primary Practice Address
Last Updated 2/2/2022
Adult outpatient pavilion
1001 E Leigh St
Richmond, VA 23219
Phone: 804-828-7999
Fax: 804-828-5941

Location Details


Years in Active Clinical Practice
Last Updated 2/2/2022
Years in Active Clinical Practice Inside US/Canada: 8
Medicaid
Last Updated 2/2/2022
Participate in the Virginia Medicaid program
Is accepting new Virginia Medicaid patients
Medicare
Last Updated 2/2/2022
Is a Medicare participating provider
Is accepting new Medicare patients
Virginia Hospital Affiliations
Last Updated 2/2/2022
VCU Health Center & MCV Hospital and Physicians (admit)
Hospital Affiliations in States Other Than Virginia
Last Updated 2/2/2022
Medical, Osteopathic, or Podiatric School
Last Updated 2/2/2022
Grad School: Saint Joseph’s University
State: Beirut
Country: Lebanon
Year Completed: 2004
Medical, Osteopathic, or Podiatric Post Grad School
Last Updated 2/2/2022
Internal Medicine
SUNY Upstate Medical University
Syracuse, NY USA
Year Internship Completed: 2008


Internal Medicine
SUNY Upstate Medical University
Syracuse, NY USA
Year Residency Completed: 2010


Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, PA USA
Year Fellowship Completed: 2013


Board Certification
Recognized by the American Board of Medical Specialties, Bureau of Osteopathic Specialists
and Boards of Certification, the American Board of Multiple Specialties in Podiatry, or Council on Podiatric Medical Education.
Last Updated 2/2/2022
Internal Medicine
Year of Initial Certifications: 2010
Current Certification Expires: 2020

Internal Medicine: Medical Oncology
Year of Initial Certifications: 2013
Current Certification Expires: 2023

Self-Designated Practice Areas
Last Updated 2/2/2022
Internal Medicine: Hematology/Oncology
Insurance Plans/Managed Care Plans Accepted
Last Updated 2/2/2022
None Reported


Honors and Awards - Optional
Last Updated 2/2/2022
Molecular Biology In Clinical Oncology
AACR
2014

Clinical Research Training Institute
American Society of Hematology
2014

Clinical Research Mentoring Program
Lymphoma Research Foundation
2015

AACR/ASCO Methods in Clinical Cancer Research
AACR/ASCO
2016

Harrison Scholarship
Massey Cancer Center
2016

Department of Internal Medicine Faculty Training Travel Grant
Department of Internal Medicine, VCU.
2017

Career Development Award
Lymphoma Research Foundation
2017

Excellence in Scholarship and Research, Clinical and Translational Science
Department of Internal Medicine, VCU.
2020

Academic Appointments
Last Updated 2/2/2022
Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 2013-2020

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Associate Professor
Years: 2020-present

Academic Appointments - Non-US
Last Updated 2/2/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 2/2/2022
. Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.
Neurooncology
Volume: 107
Date: 04 2012
www.springer.com/medicine/oncology/journal/11060

Single-agent Obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells.
Oral Oncology
Volume: Pending
Date: 11 2013
www.oraloncology.com/

A Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma.
Leuk Lymphoma.
Volume: 19
Date: 01 2017

Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
Oncotarget.
Volume: 8
Date: 05 2017

A Phase 2 Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma & Leukemia.
Volume: 9
Date: 09 2018

Choosing the right pharmacotherapy for non-Hodgkin's lymphoma: does one size fit all?
Expert Opinion Pharmacotherapy
Date: 02 2019

Marginal Zone Lymphoma : State of the Art Treatment.
Current Treatment Options in Oncology
Volume: 20
Date: 12 2019

Perspectives on chemotherapy for the management of double-hit lymphoma
Expert Opin Pharmacother .
Volume: 21
Date: 02 2020

Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome.
Leuk Lymphoma
Volume: 62
Date: 05 2021

Role of antibody-based therapy in indolent non Hodgkin’s lymphoma.
Leukemia Research reports
Date: 10 2021

Felony Conviction Information
Last Updated 2/2/2022
None Reported
Actions Taken by States/Organizations Other than the Virginia Board of Medicine
Last Updated 2/2/2022
None Reported
Virginia Board of Medicine Notices and Orders
Verified by Board
No Notices or Orders on file

Paid Claims in the last ten years
Last Updated 2/2/2022
The licensee has reported the following paid claims in the past ten years:
None Reported

Return to Normal View
Date Printed: 6/2/2024

Virginia Board of Medicine 9960 Mayland Drive, Suite 300, Henrico, VA 23233-1463